Skip to main content

BOSTON FAMILY OFFICE LLC

Family Office

Position in NVO — Novo Nordisk A S

CIK 1039807 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,770,951
+$483,231 QoQ
Shares Held
36,941
+5.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#403
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BOSTON FAMILY OFFICE LLC holds $74,645,423 across 10 Drug Manufacturers - General names. NVO ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVO
Novo Nordisk A S
This page
36,941 $1,770,951

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,770,951 36,941
2026-03-31 $1,287,720 35,040
2025-12-31 $1,888,665 37,120
2025-09-30 $1,979,494 35,673
2025-06-30 $2,462,150 35,673
2025-03-31 $2,628,165 37,848
2024-12-31 $3,854,040 44,804
2024-09-30 $5,301,472 44,524
2024-06-30 $6,172,648 43,244
2024-03-31 $5,906,913 46,004
2023-12-31 $5,073,188 49,040
2023-09-30 $4,459,697 49,040
2023-06-30 $3,968,071 24,520
2023-03-31 $3,902,112 24,520
2022-12-31 $3,882,633 28,688
2022-09-30 $2,858,185 28,688
2022-06-30 $3,658,135 32,829
2022-03-31 $3,701,185 33,329
2021-12-31 $4,135,264 36,922
2021-09-30 $3,646,267 37,978
2021-06-30 $3,223,050 38,475
2021-03-31 $2,593,984 38,475
2020-12-31 $2,687,478 38,475
2020-09-30 $2,671,319 38,475
2020-06-30 $3,051,957 46,609
2020-03-31 $2,805,982 46,611